The journal retracts the article titled, “TTF1, in the Form of Nanoparticles, Inhibits Angiogenesis, Cell Migration and Cell Invasion In Vitro and In Vivo in Human Hepatoma through STAT3 Regulation” [1], cited above. The gene discussed is TTF1; the disease is hepatocellular carcinoma.